Effects of prescription omega-3-acid ethyl esters on non--high-density lipoprotein cholesterol when coadministered with escalating doses of atorvastatin.

Mayo Clinic Proceedings
Harold BaysEvan Stein

Abstract

To evaluate the effects of prescription omega-3-acid ethyl esters on non-high-density lipoprotein cholesterol (HDL-C) levels in atorvastatin-treated patients with elevated non-HDL-C and triglyceride levels. This study, conducted between February 15, 2007, and October 22, 2007, randomized patients with elevated non-HDL-C (>160 mg/dL) and triglyceride (>or=250 mg/dL and <or=599 mg/dL) levels to double-blind treatment with prescription omega-3-acid ethyl esters, 4 g/d, or placebo for 16 weeks. Patients also received escalating dosages of open-label atorvastatin (weeks 0-8, 10 mg/d; weeks 9-12, 20 mg/d; weeks 13-16, 40 mg/d). Prescription omega-3-acid ethyl esters plus atorvastatin, 10, 20, and 40 mg/d, reduced median non-HDL-C levels by 40.2% vs 33.7% (P<.001), 46.9% vs 39.0% (P<.001), and 50.4% vs 46.3% (P<.001) compared with placebo plus the same doses of atorvastatin at the end of 8, 12, and 16 weeks, respectively. Prescription omega-3-acid ethyl esters plus atorvastatin also reduced median total cholesterol, triglyceride, and very low-density lipoprotein cholesterol levels and increased HDL-C levels to a significantly greater extent than placebo plus atorvastatin. Percent changes from baseline low-density lipoprotein-cholester...Continue Reading

References

Jan 24, 2003·Clinical Cardiology·Jonathan IsaacsohnYale B Mitchel
Apr 4, 2006·The American Journal of Cardiology·Harold Bays
Jul 13, 2006·Current Opinion in Lipidology·William S Harris, Deepti Bulchandani
Aug 22, 2006·The American Journal of Cardiology·Michael H Davidson
Sep 11, 2007·Clinical Therapeutics·Michael H DavidsonUNKNOWN COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators
Mar 11, 2008·Expert Review of Cardiovascular Therapy·Harold E BaysMichael H Davidson
Jun 4, 2008·Circulation·John J P KasteleinUNKNOWN IDEAL Study Group
Jan 13, 2009·Current Opinion in Lipidology·Janine HartwegAndrew Neil
Jan 24, 2009·Journal of the American College of Cardiology·Jennifer G RobinsonTerry A Jacobson

❮ Previous
Next ❯

Citations

Jan 18, 2013·Food & Function·Tiffany NicholsonMohammed H Moghadasian
May 1, 2013·CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne·Dugald SeelyGordon Guyatt
Aug 21, 2013·Atherosclerosis. Supplements·Angela Pirillo, Alberico L Catapano
Nov 26, 2010·International Journal of Clinical Practice·T A Jacobson
May 11, 2010·The American Journal of Cardiology·Kevin C MakiUNKNOWN COMBination of prescription Omega-3 with Simvastatin (COMBOS) Investigators
Jul 23, 2016·Lipids in Health and Disease·James BackesJulia Catini
Nov 9, 2016·Nutrition Research Reviews·Valérie LamantiaMay Faraj
May 4, 2012·Journal of Pharmacy Practice·Jennifer SanteeHeather Pace
Jun 17, 2011·Journal of Pharmacy Practice·Betsy E Brinson, Susan Miller
Feb 1, 2012·Therapeutic Advances in Drug Safety·Clement K M Ho, Simon W Walker
Feb 8, 2011·Journal of Cardiovascular Pharmacology·Kevin C MakiJohn W Marshall
Sep 16, 2010·Current Treatment Options in Cardiovascular Medicine·Andrew Paul DefilippisTerry A Jacobson
Aug 20, 2019·Circulation·Ann C Skulas-RayUNKNOWN American Heart Association Council on Arteriosclerosis, Thrombosis and Vascular Biology; Council on Lifestyle and Cardiometa
Nov 5, 2019·The Journal of Clinical Endocrinology and Metabolism·Huaizhu WuChristie M Ballantyne

❮ Previous
Next ❯

Related Concepts

Related Feeds

ApoE, Lipids & Cholesterol

Serum cholesterol, triglycerides, apolipoprotein B (APOB)-containing lipoproteins (very low-density lipoprotein (VLDL), immediate-density lipoprotein (IDL), and low-density lipoprotein (LDL), lipoprotein A (LPA)) and the total cholesterol/high-density lipoprotein (HDL) cholesterol ratio are all connected in diseases. Here is the latest research.